Advancing Oncology Drug Development with Precision Medicine

BenevolentAI- Digital redering of a cell

Traditionally a disease has been defined by its clinical presentation and observable characteristics, not by the underlying molecular mechanisms, pathways and biological processes specific to a particular patient.

References:

--

--

Uniting human and machine intelligence to discover new ways to treat disease | www.benevolent.com #Becauseitmatters #AI #DrugDiscovery #Innovation

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
BenevolentAI

Uniting human and machine intelligence to discover new ways to treat disease | www.benevolent.com #Becauseitmatters #AI #DrugDiscovery #Innovation